. Earth Science News .
China reports first swine flu death, warns of heightened risk

WHO reports mild adverse effects in China swine flu jabs
The World Health Organisation said Tuesday that four people in China had reportedly suffered mild "adverse" effects after being vaccinated against swine flu. WHO spokesman Gregory Hartl told journalists that such occurrences among a sample of 39,000 people vaccinated were expected and must not put people off being immunised against A(H1N1) swine flu. "In the case of China we are seeing reports -- we do not have first hand confirmation yet -- that out of 39,000 people vaccinated apparently four people have had adverse events," he said. "Those adverse events have all been mild, if I'm not mistaken things like muscle cramps and headaches," he added. "Adverse events are fully to be expected, especially these mild types," he underlined ahead of forthcoming mass swine flu vaccination campaigns in the United States and in Europe. The vaccines approved so far had been used in seasonal formulation for years and have been among the safest vaccines known to exist, Hartl explained. "The most important tool we have to fight this pandemic is the vaccine," he added, insisting on its importance for health workers. China began mass vaccinations against swine flu on Monday in Beijing, making one of the first nations to start inoculating its population against the virus. The most populous nation in the world has been at the forefront of international efforts to produce an A(H1N1) influenza vaccine, with at least five companies receiving government approval for the work.

GSK agrees deal for paediatric vaccines in China
British drugmaker GlaxoSmithKline (GSK) on Tuesday said it had agreed a long-term joint venture with Chinese peer Jiangsu Walvax Biotech Company to make paediatric vaccines for use in China. "GlaxoSmithKline (GSK) and Jiangsu Walvax Biotech Company (Walvax) today announced a cooperation agreement to form a long-term joint venture to develop and manufacture paediatric vaccines for use in China," said a statement. "The joint venture will produce vaccines for measles, mumps, and rubella... and potentially other paediatric vaccines. "GSK will also transfer the technology to enable the joint venture to manufacture the vaccines locally over time," it added.
by Staff Writers
Beijing (AFP) Oct 6, 2009
China on Tuesday announced its first swine flu death, saying a patient in its southwestern Tibet region had died from the disease and warning the threat from the disease could soon worsen.

In response, the government had "urgently" sent 200,000 doses of influenza A(H1N1) vaccine to the region since Sunday's death in a bid to contain the virus, China's health ministry said in a statement on its website.

"An influenza A(H1N1) sufferer in the region died after efforts to save the sufferer failed," it said.

"This is our first domestic report of a swine flu death," said the statement, which gave no further details on the victim.

However, state-run Xinhua news agency said in a report from the Tibetan regional capital Lhasa that the victim was an 18-year-old female who entered a hospital in the city on Saturday with severe flu symptoms.

China -- hit hard in the past by bird flu and Severe Acute Respiratory Syndrome (SARS) -- took swift and tough measures against the virus when it first emerged in the Americas.

This included strictly quarantining scores of foreign tourists and students merely for arriving on flights on which a virus sufferer was found.

But China has warned of a spike in cases -- and deaths -- during the winter flu season.

The health ministry said last month that "tens of millions" of people in the world's most populous country could get the virus in the coming months, adding that fatalities would be "unavoidable".

The health ministry released a separate statement on its website after reporting the Tibet death, warning of a growing risk from the disease.

"High-risk populations that already have underlying health conditions face especially great danger," it said.

However, in an apparent attempt to head off any panic over the fatality, it also stressed that authorities had reacted proactively to the disease and put in place systems allowing them to move rapidly against any outbreak.

The ministry statement also said China had now confirmed a total of 21,453 cases since swine flu first emerged, including 13 people who remained in serious condition.

China began mass vaccinations against swine flu last month, making it one of the first nations to start inoculating its population against the virus.

It has been at the forefront of efforts to develop vaccines, with several Chinese pharmaceutical companies already receiving government approval for versions they had developed.

However, it has warned that demand would likely exceed supply.

The health ministry has said it plans to vaccinate 65 million people, or five percent of the country's total population of 1.3 billion, before year's end.

It said late last month that China would have a stockpile of 26 million swine flu vaccine shots by the end of October, with that number eventually surging to 100 million, but not before year's end.

Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


World swine flu cases surge, deaths also up: report
Washington (AFP) Oct 5, 2009
The number of swine flu cases worldwide has jumped by at least 24,000 in two weeks to exceed 343,000, while deaths from the A(H1N1) virus edged up to more than 4,100, a US health agency said Monday. "The World Health Organization (WHO) regions have reported over 343,298 laboratory-confirmed cases of 2009 H1N1 with at least 4,108 deaths, which is an increase of at least 24,373 cases and 191 ... read more







The content herein, unless otherwise known to be public domain, are Copyright 1995-2009 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement